November 16, 2026 at 12:07 PM UTC
InMed Pharmaceuticals Inc. reports acquisition or asset disposition
InMed Pharmaceuticals Inc. filed an 8-K covering an acquisition or disposition of assets and results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 16, 2026 at 12:03 PM UTC
Open official source